A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer

NCT00882310 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Capecitabine

Sponsor

Columbia University